- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Hemoperfusion market will register a 18.7% CAGR in terms of revenue, the global market size will reach US$ 554.1 million by 2024, from US$ 278.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemoperfusion business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemoperfusion value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Kaneka
Asahi-Kasei
Aier
Toray Medical
Zibo Kangbei
Cytosorbents
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemoperfusion consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemoperfusion market by identifying its various subsegments.
Focuses on the key global Hemoperfusion manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemoperfusion with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemoperfusion submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global Hemoperfusion Market Growth 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemoperfusion Consumption 2014-2024
2.1.2 Hemoperfusion Consumption CAGR by Region
2.2 Hemoperfusion Segment by Type
2.2.1 Activated Carbon Adsorption
2.2.2 Resin Adsorption
2.3 Hemoperfusion Consumption by Type
2.3.1 Global Hemoperfusion Consumption Market Share by Type (2014-2019)
2.3.2 Global Hemoperfusion Revenue and Market Share by Type (2014-2019)
2.3.3 Global Hemoperfusion Sale Price by Type (2014-2019)
2.4 Hemoperfusion Segment by Application
2.4.1 Hepatic Encephalopathy
2.4.2 Certain Autoimmune Diseases
2.4.3 Drug Overdose
2.4.4 Specific Intoxications
2.4.5 Others
2.5 Hemoperfusion Consumption by Application
2.5.1 Global Hemoperfusion Consumption Market Share by Application (2014-2019)
2.5.2 Global Hemoperfusion Value and Market Share by Application (2014-2019)
2.5.3 Global Hemoperfusion Sale Price by Application (2014-2019)
3 Global Hemoperfusion by Manufacturers
3.1 Global Hemoperfusion Sales Market Share by Manufacturers
3.1.1 Global Hemoperfusion Sales by Manufacturers (2017-2019)
3.1.2 Global Hemoperfusion Sales Market Share by Manufacturers (2017-2019)
3.2 Global Hemoperfusion Revenue Market Share by Manufacturers
3.2.1 Global Hemoperfusion Revenue by Manufacturers (2017-2019)
3.2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Hemoperfusion Sale Price by Manufacturers
3.4 Global Hemoperfusion Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Hemoperfusion Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hemoperfusion by Regions
4.1 Hemoperfusion by Regions
4.1.1 Global Hemoperfusion Consumption by Regions
4.1.2 Global Hemoperfusion Value by Regions
4.2 Americas Hemoperfusion Consumption Growth
4.3 APAC Hemoperfusion Consumption Growth
4.4 Europe Hemoperfusion Consumption Growth
4.5 Middle East & Africa Hemoperfusion Consumption Growth
5 Americas
5.1 Americas Hemoperfusion Consumption by Countries
5.1.1 Americas Hemoperfusion Consumption by Countries (2014-2019)
5.1.2 Americas Hemoperfusion Value by Countries (2014-2019)
5.2 Americas Hemoperfusion Consumption by Type
5.3 Americas Hemoperfusion Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hemoperfusion Consumption by Countries
6.1.1 APAC Hemoperfusion Consumption by Countries (2014-2019)
6.1.2 APAC Hemoperfusion Value by Countries (2014-2019)
6.2 APAC Hemoperfusion Consumption by Type
6.3 APAC Hemoperfusion Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Hemoperfusion by Countries
7.1.1 Europe Hemoperfusion Consumption by Countries (2014-2019)
7.1.2 Europe Hemoperfusion Value by Countries (2014-2019)
7.2 Europe Hemoperfusion Consumption by Type
7.3 Europe Hemoperfusion Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hemoperfusion by Countries
8.1.1 Middle East & Africa Hemoperfusion Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Hemoperfusion Value by Countries (2014-2019)
8.2 Middle East & Africa Hemoperfusion Consumption by Type
8.3 Middle East & Africa Hemoperfusion Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hemoperfusion Distributors
10.3 Hemoperfusion Customer
11 Global Hemoperfusion Market Forecast
11.1 Global Hemoperfusion Consumption Forecast (2019-2024)
11.2 Global Hemoperfusion Forecast by Regions
11.2.1 Global Hemoperfusion Forecast by Regions (2019-2024)
11.2.2 Global Hemoperfusion Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hemoperfusion Forecast by Type
11.8 Global Hemoperfusion Forecast by Application
12 Key Players Analysis
12.1 Jafron Biomedical
12.1.1 Company Details
12.1.2 Hemoperfusion Product Offered
12.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Jafron Biomedical News
12.2 Baxter (Gambro)
12.2.1 Company Details
12.2.2 Hemoperfusion Product Offered
12.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Baxter (Gambro) News
12.3 Biosun Medical
12.3.1 Company Details
12.3.2 Hemoperfusion Product Offered
12.3.3 Biosun Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Biosun Medical News
12.4 Kaneka
12.4.1 Company Details
12.4.2 Hemoperfusion Product Offered
12.4.3 Kaneka Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Kaneka News
12.5 Asahi-Kasei
12.5.1 Company Details
12.5.2 Hemoperfusion Product Offered
12.5.3 Asahi-Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Asahi-Kasei News
12.6 Aier
12.6.1 Company Details
12.6.2 Hemoperfusion Product Offered
12.6.3 Aier Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Aier News
12.7 Toray Medical
12.7.1 Company Details
12.7.2 Hemoperfusion Product Offered
12.7.3 Toray Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Toray Medical News
12.8 Zibo Kangbei
12.8.1 Company Details
12.8.2 Hemoperfusion Product Offered
12.8.3 Zibo Kangbei Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Zibo Kangbei News
12.9 Cytosorbents
12.9.1 Company Details
12.9.2 Hemoperfusion Product Offered
12.9.3 Cytosorbents Hemoperfusion Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Cytosorbents News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Hemoperfusion
Table Product Specifications of Hemoperfusion
Figure Hemoperfusion Report Years Considered
Figure Market Resear
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
